TABLE 4.
HBV-human junctions in HCC clinical samples determined by RAISING-sequencing
Patient ID | No. total reads | HBV junction position | HBV genome | Human chromosome | Human junction position | Human gene | (Figure 3) |
---|---|---|---|---|---|---|---|
HCC-6 | 13 | 1800 | X | Chr15 | 20503423 | HERC2P3 | → #1 |
(nontumor tissue) | 5 | 1804 | X | Chr7 | 1081173 | C7orf50 | → #2 |
HCC-33 | 1009 | 1753 | X | Chr18 | 67700005 | AC114689.3 | → #1 |
(nontumor tissue) | 77 | 1713 | X | Chr2 | 200147042 | (intergenic) | |
40 | 1779 | X | Chr3 | 139268965 | MRPS22 | ||
38 | 1634 | X | Chr4 | 185836717 | SORBS2 | ||
28 | 1733 | X | Chr2 | 226775817 | IRS1 | ||
22 | 1819 | C, X | Chr14 | 71388644 | SIPA1L1 | ||
20 | 1654 | X | Chr4 | 103537128 | (intergenic) | ||
16 | 1753 | X | Chr4 | 73897495 | (intergenic) | ||
16 | 1828 | C, X | Chr9 | 95148096 | FANCC | ||
10 | 1820 | C, X | Chr1 | 173944363 | RC3H1 | ||
HCC-46 | 5965 | 1676 | X | ChrX | 27176279 | AC107419.1 | → #1 |
(nontumor tissue) | 1051 | 1646 | X | Chr12 | 77598319 | NAV3 | → #2 |
790 | 1785 | X | Chr4 | 102824385 | UBE2D3 | → #3 | |
587 | 1751 | X | Chr1 | 198862191 | MIR181A1HG | ||
218 | 1818 | C, X | Chr10 | 124502003 | LHPP | ||
181 | 1829 | C, X | Chr2 | 215420541 | FN1 | ||
84 | 1821 | C, X | Chr1 | 235499700 | B3GALNT2 | ||
78 | 1928 | C | Chr2 | 177509515 | AGPS | ||
46 | 1829 | C, X | Chr11 | 11206373 | (intergenic) | ||
22 | 809 | P, S | Chr8 | 88734382 | AC090578.1 | ||
22 | 1827 | C, X | Chr2 | 195217190 | (intergenic) | ||
18 | 1680 | X | Chr2 | 235683893 | AGAP1 | ||
10 | 1775 | X | Chr18 | 64561691 | (intergenic) | ||
9 | 1826 | C, X | Chr8 | 135688215 | (intergenic) | ||
8 | 1687 | X | Chr12 | 34822229 | (intergenic) | ||
8 | 1824 | C, X | Chr11 | 46364499 | DGKZ |
Abbreviation: RAISING, Rapid Amplification of Integration Site without Interference by Genomic DNA contamination.